Back

Prognostic significance of the advanced lung cancer inflammation index in acute coronary syndrome patients: a systematic review and meta-analysis

29 August 2026 (11:15 - 11:45)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes: new biomarkers for risk stratification and machine learning Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Santiago Saenz Ancira

Jacobi Medical Centre, Bronx (United States of America)

3 More presentations in this session

Presentation thumbnail
Pre-procedural machine learning model including prior SGLT2 inhibitor therapy improves early risk stratification for contrast-associated kidney injury in acute coronary syndrome
Doctor J. Andreu Cayuelas (Cartagena, ES)
Abstract Slides
Presentation thumbnail
Point-of-care high-sensitivity troponin testing for rapid chest pain triage in emergency primary care: preliminary efficacy findings from the OUT-POC Study
Doctor T. Johannessen (Oslo, NO)
Abstract Slides
Presentation thumbnail
CRP reveals an inflammatory, non-calcified coronary endotype in SMuRF-less individuals and enables efficient two-stage screening for subclinical atherosclerosis
Doctor S. Fathieh (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Acute coronary syndromes: new biomarkers for risk stratification and machine learning

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of vascular inflammation biomarkers over clinical risk factors for cardiovascular risk : a meta-analysis
17 April 2021
thumbnail
Congress Presentation
Characteristics, management, and outcome of patients with acute coronary syndromes and cancer: Insights from the EYESHOT-2 registry
20 June 2025
thumbnail
Congress Presentation
Prognostic value of advanced lung cancer inflammation index in predicting 1-year mortality post-PCI in STEMI patients
30 August 2025
thumbnail
Congress Presentation
Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources